Welcome to LookChem.com Sign In|Join Free
  • or
1,2,4-Benzotriazin-3-amine, 8-(methylthio)-, 1-oxide is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

494226-32-3

Post Buying Request

494226-32-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

494226-32-3 Usage

Chemical structure

1,2,4-Benzotriazin-3-amine, 8-(methylthio)-, 1-oxide

Classification

Nootropic

Function

Enhances cognitive function and memory

Mechanism of action

Increases the levels of acetylcholine in the brain

Neurotransmitter involved

Acetylcholine

Importance of neurotransmitter

Important for learning and memory

Additional properties

Antioxidant properties, may protect the brain from oxidative stress

Potential applications

Treating age-related cognitive decline and neurodegenerative diseases

Availability

Available as a dietary supplement

Clinical evidence

Limited clinical evidence to support effectiveness

Side effects

Potential side effects, may vary by individual

Drug interactions

May interact with other medications

Research status

Further research needed to fully understand effects and safety

Check Digit Verification of cas no

The CAS Registry Mumber 494226-32-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,9,4,2,2 and 6 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 494226-32:
(8*4)+(7*9)+(6*4)+(5*2)+(4*2)+(3*6)+(2*3)+(1*2)=163
163 % 10 = 3
So 494226-32-3 is a valid CAS Registry Number.

494226-32-3Upstream product

494226-32-3Downstream Products

494226-32-3Relevant academic research and scientific papers

Benzoazine mono-N-oxides and benzoazine 1,4 dioxides and compositions therefrom for the therapeutic use in cancer treatments

-

, (2008/06/13)

The present invention relates to a synergetistic composition comprising one or more benzoazine-mono-N-oxides, and one or more benzoazine 1,4 dioxides for use in cancer therapy. The invention also provides a range of novel 1,2,4 benzoazine-mono-N-oxides and related analogues. These can be used as potentiators of the cytotoxicity of existing anticancer drugs and therapies for cancer treatment.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 494226-32-3